Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07135180

Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups

The aim of this study is to evaluate the underlying mechanisms of consuming two capsules (each containing 250 mg of Cordyceps cicadae mycelium, for a total intake of 500 mg) of Grape King's Cordyceps cicadae mycelium through a clinical human trial. By including participants from different age groups, the study investigates whether improvements in visual acuity and the alleviation of eye fatigue are associated with changes in ocular accommodation, tear film stability, and blood circulation. The ultimate goal is to develop a health supplement beneficial for vision.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

30 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chung Shan Medical University Hui-Wen Lin lab

Taichung, 40201, Taiwan

About this study

Over the past decade, vision problems caused by electronic screen use across all age groups have gradually shifted from being primarily occupational health issues to broader public health concerns. Moreover, studies have shown that prolonged computer use may lead to blurred vision at near or far distances-one of the hallmark symptoms of Computer Vision Syndrome (CVS), also known as Digital Eye Strain (DES). A key contributing factor is inaccurate accommodative response, either due to underaccommodation or overaccommodation while focusing on a visual target, leading to visual fatigue.

Sheedy et al. identified common symptoms of visual fatigue, including eye tiredness, discomfort, burning, irritation, pain, soreness, eye ache, double vision, photophobia, blurriness, itching, tearing, dryness, and a foreign body sensation. These symptoms are generally classified into two categories: the first, external symptoms-such as burning, irritation, dryness, and tearing-are associated with dry eye syndrome; the second, internal symptoms-such as eye fatigue, headache, ocular pain, diplopia, and blurred vision-are typically linked to refractive errors, accommodative dysfunction, or convergence anomalies.

In addition, a study by Tosha et al. found that subjects who experienced greater visual discomfort after prolonged computer use exhibited a significant increase in accommodative lag, suggesting a link to accommodative fatigue. Overall, these conditions are closely related to visual fatigue, and if left unmanaged, may impair visual function over time and potentially contribute to the progression of myopia.

Therefore, appropriately managing screen time, along with adequate visual rest and eye care strategies, is essential for maintaining healthy accommodation and visual function. Previous studies have demonstrated that Cordyceps cicadae mycelium can effectively relieve eye fatigue and improve visual acuity; however, the underlying mechanisms remain unclear. The Cordyceps cicadae mycelium used in this study has passed 16 safety evaluation tests and has been granted a New Dietary Ingredient (NDI No. 834) number by the U.S. Food and Drug Administration (FDA), as well as food clearance approval by Japanese customs. The product is supplied by Grape King Bio. This study aims to further investigate the eye-protective mechanisms of Cordyceps cicadae mycelium and its beneficial effects on visual health across different age groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People with myopia less than 700 degrees
  • Willing to participate in this study and sign the consent form

Exclusion criteria

  • (1) Those who have recently consumed related eye care products
  • (2) Those who have had eye infections or surgery in the past three months
  • (3) Those who have been diagnosed with eye diseases by an ophthalmologist (such as glaucoma, cataracts, macular degeneration, diabetic retinopathy, etc., or have undergone eye surgery such as cataract surgery, retinal laser surgery, myopia laser surgery, etc., which will be excluded before accepting the case)
  • (4) Those who are allergic to cicada fungus

Treatment and study plan

Cordyceps cicadae

Dietary Supplement

Cordyceps cicadae 500mg

Blank control

Dietary Supplement

Blank control

Primary outcomes

  1. Eye fatigue questionnaire

    Time frame: 3 hours

    The Ocular Surface Disease Index (OSDI) was used to assess visual fatigue. The subjects were asked to fill in the questionnaire before and after taking the medicine, and the scores were calculated. Symptoms include eyestrain, discomfort, burning, irritation, pain, soreness, eye pain, double vision, photophobia, blurriness, itching, tearing, dryness, and foreign body sensation

  2. Tear break-up time

    Time frame: 3 hours

    Tear film break-up time (TBUT) on the corneal surface will be recorded in seconds using corneal topography.

  3. Accommodative Facility

    Time frame: 3 hours

    Use +/- 0.50D flip mirror and special optometry cards to test the number of optometry cards that the patient can read within one minute and record the number of flip cycles.

  4. Visual acuity measurement

    Time frame: 3 hours

    Examinations include (a) distance visual acuity (DVA) and (b) near visual acuity (NVA), recorded using the Snellen chart.

  5. Choroidal thickness test

    Time frame: 3 hours

    Heidelberg SPECTRALIS optical coherence tomography (OCT) was used to examine the choroid thickness in micrometer of the subjects.

  6. Tear meniscus height (TMH)

    Time frame: 3 hours

    Tear meniscus height (TMH) will be evaluated using slit-lamp biomicroscopy and recorded in millimeters.

  7. Meibomian gland observation

    Time frame: 3 hours

    The meibomian glands will be evaluated using corneal topography to document their morphology, quantity, and size.

Secondary outcomes

  1. Intraocular Pressure

    Time frame: 3 hours

    The intraocular pressure (IOP) of the subjects was measured by non-contact intraocular pressure measurement in mmHg.

Sponsors and collaborators

Lead sponsor

China Medical University Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Aug 21, 2025
Registry last updated
Aug 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.